Publications

Found 349 results
2026
Barnich N, Arthur JC, Buisson A, Campbell BJ, Carbonnel F, Chassaing B, Coombes BK, Denizot J, Dogan B, Faith J et al..  2026.  Adherent-invasive Escherichia coli in Crohn's disease: the 25th anniversary.. Gut. 75(2):411-424.
Gordon ES, Goc J, Grier A, Thomas C, Lentine J, Sockolow RE, Sonnenberg GF.  2026.  Altered Gut Microbiota in Pediatric Quiescent Crohn's Disease Patients with Iron Deficiency Anemia.. Inflamm Bowel Dis. 32(2):303-313.
Pan X, Conroy A, Ngima TS, Mesko M, Morzhanaeva O, Li A, Marino J, Westblade LF, Grier A, Bacher P et al..  2026.  Antifungal therapy improves microbiome dynamics in inflammatory bowel disease.. Nat Med. 32(9):3385-3395.
Martini GRios, Hofmann P, Kamps A-K, Weichberger A, Tikhonova E, Conroy A, Pan X, Namuch DMilagros, Rathjens L, Bergfeld A et al..  2026.  Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation.. Immunity. 59(9):2545-2561.e10.
Lyu M, Sonnenberg GF.  2026.  B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine.. J Exp Med. 223(6)
Longman RS.  2026.  Cell Adhesion Molecule 1 Emerges as a Biomarker and Therapeutic Opportunity in Inflammatory Bowel Disease.. Cell Mol Gastroenterol Hepatol. 20(1):101648.
Bashir H, Sanidad KZ, Ravisankar P, Banks KM, Bose A, Yu S, McGrath JJC, Carrow HC, Kim TK, Troxell CA et al..  2026.  Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.. Cancer Cell. 44(7):1458-1476.e13.
Kim MJoon, Sonnenberg GF.  2026.  Diet-induced death: microbiome-mediated lipid stress reduces intestinal ILC3s.. Trends Immunol. 47(4):252-254.
Kim S, Kim H, Yim YShin, Ha S, Atarashi K, Tan TGuan, Longman RS, Honda K, Littman DR, Choi GB et al..  2026.  Editorial Expression of Concern: Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring.. Nature. 658(8137):E7.
Pires S, Longman RS.  2026.  Emergency granulopoiesis and innate immune memory in inflammatory bowel disease.. Trends Immunol.
Pires S, Yang W, Longman RS.  2026.  Emerging insights into TL1A biology may guide precision therapy for IBD.. J Exp Med. 223(9)
Maldarelli GA, Marino J, Lee JR, Westblade LF, Hovan M, Douglass C, Davidson E, Longman RS, Satlin MJ.  2026.  Enteric Microbiome Features that Contribute to Gram-Negative Bloodstream Infections in Hematopoietic Cell Transplant Recipients Colonized with Fluoroquinolone-Resistant Enterobacterales.. J Infect Dis.
Kang L, Sonnenberg GF.  2026.  Epigenetics control lineage decisions during hematopoiesis of innate lymphocytes.. Cell Mol Immunol. 23(4):347-348.
Lin Q, Liu RE, Wang Q, Kang L, Chen B, Lu Y, Zhang Y, Gu Z, Zhou Y, Liu H et al..  2026.  Fibroblasts restrain gut inflammation by IGF1-dependent regulation of innate lymphocytes.. Science. 393(6818):1347-1353.
Zhao FR, Kleverov M, Winkler ES, Williams RB, Janova H, Droit L, Wang L, Li T-T, Heath L, Jung A et al..  2026.  Gut microbe-derived short-chain fatty acids regulate alphavirus arthritis and macrophage activation in mice.. J Clin Invest. 136(14)
Gladstone JL, Sonnenberg GF.  2026.  Gut microbiota and metabolic control of immune checkpoint blockade in cancer.. Cell Metab. 38(7):1297-1314.
Gladstone JL, Sonnenberg GF.  2026.  Gut microbiota and metabolic control of immune checkpoint blockade in cancer.. Cell Metab. 38(7):1511.
Brown JA, Amir M, Yu S, Wong DSH, Gu J, Balaji U, Parkhurst CN, Hong S, Hart LR, Carrow HC et al..  2026.  Gut microbiota promotes immune tolerance at the maternal-fetal interface.. Cell. 189(1):196-214.e24.
Menezes-Silva L, Jeong M, Carr C, Schneider RM, Pires S, Codo AC, Uddin J, Grier A, Longman RS, Camara NOlsen Sara et al..  2026.  Hormonal rewiring of immunity during dietary restriction ensures host defense and systemic glucose conservation.. Immunity. 59(3):700-716.e9.
Pires S, Yang W, Frigerio S, Louis C, Scott C, Zhou YLin, Cardakli E, Tran N, Hassan-Zahraee M, Ye Z et al..  2026.  Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of tumor-promoting neutrophils.. Immunity. 59(2):372-387.e7.
Ahmed A, Sonnenberg GF.  2026.  Interleukin-23 biology linking mucosal immunity to autoimmune diseases and cancer.. Trends Immunol. 47(5):397-408.
Li Z, Liu S, Jin W, Xiao L, Kester O, Bullen N, Chen X, Chan UIn, Owiredu J, Li Z et al..  2026.  Isoleucine and valine promote prostate cancer progression via propionyl-CoA-mediated cholesterol metabolism.. Nat Metab. 8(8):1772-1790.
Goto S, Deshpande V, Yilmaz ÖH, Goto N.  2026.  Lineage plasticity driven by GATA6 loss fuels colorectal cancer metastasis.. Cell Stem Cell. 33(8):1304-1323.e7.
Qiao S, Li T-T, Jeong M, Liu C, Mizutani S, Hwang S-M, Li Y, Lyu M, Nishiyama K, Tang Y-A et al..  2026.  Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity.. Cell Host Microbe. 34(1):18-34.e14.
Towers BE, Sonnenberg GF.  2026.  Microniche control of innate lymphocyte biology in the gut.. Int Immunol. 38(4):222-235.